World Journal of Endocrine Surgery

Register      Login

VOLUME 2 , ISSUE 2 ( May-August, 2010 ) > List of Articles

RESEARCH ARTICLE

Radioiodine for Treatment of Graves' Disease in Pediatric Population: An Ideal Treatment

S Gambhir, S Barai

Citation Information : Gambhir S, Barai S. Radioiodine for Treatment of Graves' Disease in Pediatric Population: An Ideal Treatment. World J Endoc Surg 2010; 2 (2):77-80.

DOI: 10.5005/jp-journals-10002-1026

Published Online: 01-08-2010

Copyright Statement:  Copyright © 2010; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Graves’ disease in childhood: Advances in management with antithyroid drug therapy. Horm Res 2009;71(6):310-17. Epub 2009 Jun 6.
  2. History of the discovery and early use of radioactive iodine. JAMA 1983;250:2042-44.
  3. Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab Oct 2000;85(10):3678-82.
  4. Organization of Pediatric Endocrinologists of Northern California Collaborative Graves’ Disease Study Group. Predicting the likelihood of remission in children with Graves’ disease: A prospective, multicenter study. Pediatrics. Mar 2008;121(3):e481-88. Epub 2008.
  5. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves’ disease. N Engl J Med 1977;297:173-76.
  6. Graves’ hyperthyroidism: How long should antithyroid drug therapy be continued to achieve remission? Nat Clin Pract Endocrinol Metab 2006;2:2-3.
  7. The treatment of Graves’ disease in children. J Pediatr Endocrinol Metab Sep 2006;19(9):1095-111.
  8. Clinical review 99: The management of Graves’ disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-76.
  9. Could total thyroidectomy become the standard treatment for Graves’ disease? Surg Today 2010;40(1):22-25.
  10. Morbidity after subtotal and total thyroidectomy in patients with Graves’ disease: The basis for decision-making regarding surgical indication and extent of resection. Z Arztl Fortbild Qualitatssich May 2004;98Suppl 5:45-53.
  11. Surgical treatment of Graves’ disease: Evidence-based approach. World J Surg Jul 2008;32(7):1269-77.
  12. Thyroid surgery in historical perspective. J Med Liban 1970;23:537-51.
  13. History of the discovery and early use of radioactive iodine. JAMA 1983;250:2042-44.
  14. Radioiodine treatment for pediatric hyperthyroid Grave's disease. Eur J Pediatr Oct 2009;168(10):1165-69.
  15. Calculation of the radioiodine dose for the treatment of Graves’ hyperthyroidism: Is more than seventhousand rad target dose necessary? Thyroid 1999;9(9):865-69.
  16. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves’ disease resistant to antithyroid drugs. Hell J Nucl Med Sep-Dec 2005;8(3):158-61.
  17. Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 2003;111:745-49.
  18. Treatment of childhood Graves’ disease. A review with emphasis on radioiodine treatment. Cleveland Clin J Med 1988;55:373-82.
  19. Radioiodine-induced thyroid storm. Case report and literature review. Am J Med Aug 1983;75(2):353-59.
  20. Radioiodine therapy and thyrostatic drugs and iodine. Eur J Nucl Med Mol Imaging 2002;29(Suppl 2):S486–S91.
  21. Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med 1998;338:73-73.
  22. Radioiodine treatment, ablation, and ophthalmopathy: A balanced perspective. Thyroid 1997;7: 241-45.
  23. Association between radioiodine therapy for Graves’ hyperthyroidism and thyroidassociated ophthalmopathy. NT Ophthalmol Aug 2010; 30(4):397-405.
  24. Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves’ orbitopathy: A retrospective cohort study. J Clin Endocrinol Metab Mar 2010;95(3):1333-37. Epub 2010 Jan 8.
  25. Radiation carcinogenesis: Lessons from Chernobyl. Oncogene Dec 2008;27 Suppl 2:S9-18.
  26. Thyroid cancer after external or internal ionizing irradiation. Hell J Nucl Med Sep-Dec 2009;12(3):266-70.
  27. Iodine deficiency in Belarusian children as a possible factor stimulating the irradiation of the thyroid gland during the Chernobyl catastrophe. Environ Health Perspect. Dec 1997;105 Suppl 6:1487-90.
  28. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. JAMA 2004;292:2600-13.
  29. Thyroid cancer risk after thyroid examination with 131I: A populationbased cohort study in Sweden. Int J Cancer 2003;106:580-87.
  30. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 1974;38:976-98.
  31. Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine. J Clin Endocrinol Metab 1962;22:8-17.
  32. Clinical review 99: The management of Graves’ disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-76.
  33. A thirty-six year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients. J Clin Endocrinol Metab 2004;89: 4229-33.
  34. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring. Int J Radiat Oncol Biol Phys Oct 1;2005;63(2):449-55.
  35. Genetic effects of the atomic bombs: A reappraisal. Science 1981;213:1220-27.
  36. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. J Nucl Med 1976;17:826-35.
  37. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. JAMA 1968;205:855-62.
  38. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study. Lancet Jun 19, 1999;353(9170):2111-15.
  39. Comparative analysis of dosimetry parameters for nuclear medicine. ORISE Report 99-1064, 1999. Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium, Gatlinburg, TN, 1996;532-51.
  40. Health effects of exposure to low levels of ionizing radiations: Time for reassessment? Washington, DC: National Academy of Science, 1998.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.